GlaxoSmithKline, Theravance tout new data on COPD drugs

In the race for new COPD drugs, GlaxoSmithKline ($GSK) and Theravance ($THRX) have released new data from a slew of late-stage studies of their LAMA/LABA combo for COPD. The key finding is that their…
Read the full story: News